期刊文献+

慢性粒细胞白血病cyclin D2基因的表达研究 被引量:5

Cyclin D2 expression in chronic myelogenous leukemia
原文传递
导出
摘要 目的 研究cyclinD2基因表达与慢性粒细胞白血病 (CML)特征性的P2 10 BCR ABL蛋白酪氨酸激酶活性之间的相关性。方法 以RT PCR、免疫印迹法及流式细胞术检测cyclinD2基因在BCR ABL +K5 6 2细胞系中的表达。通过表达抗ABL蛋白酪氨酸激酶区胞内抗体的模型即K5 6 2 ib eGFP细胞 ,检测cyclinD2表达的变化。结果 在P2 10 BCR ABL 蛋白酪氨酸激酶活性受抑制的K5 6 2 ib eGFP细胞中 ,cyclinD2的表达 (18.90 % )明显低于K5 6 2细胞组 (48.10 % ) ,且K5 6 2 ib eGFP组S期细胞比例(40 4 0 % )也明显低于K5 6 2细胞组 (6 4 .34% )。结论 cyclinD2可能是CMLP2 10 BCR ABL 蛋白酪氨酸激酶下游相关信号传递分子 ,其表达增高可能促进了CML细胞的过度增殖。 Objective To investigate the relationship between cyclin D2 and P210 BCR/ABL tyrosine kinase in chronic myelogenous leukemia(CML). Methods RT-PCR,Western blot and flow cytometry were performed to detect the expression of cyclin D2 in K562 cells and in K562-ib-eGFP cells which express intracellular single-chain antibody (sFv, intrabody) against ABL tyrosine kinase domain. Results Cyclin D2 expression in K562-ib-eGFP cells was 18.90% which was lower than that of control K562 cells(48.10%),and the number of S-phase cells in K562-ib-eGFP was 40.40% which was much lower than that in K562 cells(64.34%). Conclusion Cyclin D2 is a potential down-stream signal molecule of the p210 BCR/ABL tyrosine kinase in CML. The altered expression of cyclin D2 may contribute to the over proliferation of CML cells.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2004年第2期103-105,共3页 Chinese Journal of Hematology
关键词 慢性粒细胞白血病 CYCLIN D2基因 信号传递分子 酪氨酸激酶 恶性克隆性疾病 Genes,cyclin D2 Leukemia, myeloid, chronic Fusion proteins, bcr-abl Protein tyrosine kinase
  • 相关文献

参考文献1

二级参考文献10

  • 1[1]Lugo TG,Pendergast AM,Muller AJ,et al.Tyrosine kinase activity and transformation potency of bcr-abl onc ogene products.Science,1990,247:1079-1082
  • 2[2]Chen SY,Bagley J,Marasco WA.Intracellular antibodiesas a new class of therapeutic molecules for gene therapy.Hum Gene Ther,1994,5:595-601
  • 3[3]Naviaux RK,Costanzi E,Haas M,et al.The pCL vector system: rapid ptoduction of helper-free,high-titer,recombinant retroviruses.J Virol,1996,70:5701-5705
  • 4[4]Pui JC,Allman D,Xu L,et al.Notch l expression in early lymphopoiesis influence B versus T lineage determination.Immunity,1999,11:299-308
  • 5[5]Jennifer HR,Joseph GS,Thomas AW,et al.Phenotypic knockout of the high-affinity human interleukin 2 receptor by intracellular single-chain antibodies against the α sub-unit of the receptor.Proc Natl Acad Sci USA,1993,90:3137-3141
  • 6[6]Robert C Zhao,Jiang Y,Catherine M.Verfaillie.A model of human p210BCR/ABC-mediated chronic myeloid leukemia by transduction of normal human CD34+ cells with a BCR/ABL-containing retroviral vector.Blood,2001,97:2406-2412
  • 7[7]Linda JP,Ann TE,Edwin GK.Charactehzation of affinity-purified insulin receptor/Kinase: Effects of dithiothreitaol on receptor/kinase function.J Biol Chem,1986,261:3782-3789
  • 8[8]Evans BD,Smith IE,Shorthouse A J,et al.A comparison of the response of human lung cell carcinoma to vindesine and vincristine.Br J Cancer,1982,45:466-468
  • 9[9]Gishizky ML,Witte ON.Initiation of deregulated growth of multipotent progenitor cells by bcr-abl ir vitro.Science,1992,256:836-839
  • 10[10]Bedi A,Zehnbauer BA,Barber JP,et al.Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia.Blood,1994,83:2038-2044

共引文献3

同被引文献44

  • 1秦亚溱,刘艳荣,李金兰,王卉,常艳,付家瑜,阮国瑞,史惠琳,丘镜滢,陆道培,陈珊珊.两例Ph染色体阳性慢性粒细胞白血病患者具有少见型bcr/abl融合基因[J].中华血液学杂志,2004,25(7):409-412. 被引量:6
  • 2Radosevic N, Delmer A, Tang R, et al. Cell cyclin regulatory protein expression in fresh acute myeloid leukemia ceils and after drug exposure[J]. Leukemia, 2001, 15(4): 559-566.
  • 3Coqueret O. Linking cyclins to transcriptional control[J]. Gene, 2002, 299(1-2): 35-55.
  • 4Fujii M, IshiguroR, YamashitaT, etal. CyclinD1 amplification correlates with early recurrence of squamous cell carcinoma of the tongue[J]. Cancer Lett, 2001, 172 (2): 187-192.
  • 5Khoo ML, Ezzat S, Freeman JL, et al. CyclinD1 protein expression predicts metastatic behavior in thyroid papillary microcarcinomas but is not associated with gene ampllfication[J]. J Clin Endocrinol Metab, 2002, 87(4): 1810-1813.
  • 6Jiang W, Kahn SM, Tonita N, et al. Amplification and expression of the human cyclin D gene in esophageal cancer[J]. Cancer Res, 1992, 52(10): 2980-2983.
  • 7Gillett C, Fantl V, Smith R, et al. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining [J]. Cancer Res, 1994, 54(7): 1812-1817.
  • 8Hirama T, Koeffler HP. Role of the cyclin-dependent kinase inhibitors in the development of cancer[J]. Blood, 1995, 86(3): 841-854.
  • 9Decker T, Schneller F, Hipp S, et al. Cell cycle progression of chronic leukemia ceils is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the inhibitor p27 [J]. Leukemia, 2002, 16(3): 327-334.
  • 10Vlahovic G, Crawford J. Activation of tyrosine kinases in cancer. Oncologist, 2003,8:531 - 538.

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部